pneumocystis jirovecii-derived kexin protein derivative (Nxt Biologics)

N/A

Report date: 2025/03/20 09:44:20

Base Information

Drug Namepneumocystis jirovecii-derived kexin protein derivative (Nxt Biologics)

Drug Alias Namepneumocystis pneumonia vaccine (Nxt Biologics)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsFungal pneumonia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNXT BIOLOGICS

China Registration ClassN/A

Develop Information

Active CompaniesNXT BIOLOGICS

Inactive CompaniesN/A

Active IndicationsFungal pneumonia

Inactive IndicationsN/A

Other Information

ATC CodeN/A